| scholarly article | Q13442814 |
| P50 | author | Kathleen M Hill Gallant | Q90099490 |
| P2093 | author name string | Munro Peacock | |
| Anthony Acton | |||
| Robert V Considine | |||
| Brenda M Cacucci | |||
| Christine E Gupta | |||
| Elizabeth Grethen | |||
| RoseMarie Jones | |||
| P2860 | cites work | FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis | Q24319751 |
| Control of bone mass and remodeling by PTH receptor signaling in osteocytes | Q27300741 | ||
| Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis | Q28265821 | ||
| Serum immunoreactive-leptin concentrations in normal-weight and obese humans | Q29617230 | ||
| Leptin reduces ovariectomy-induced bone loss in rats | Q74222960 | ||
| The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults | Q79735488 | ||
| Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index | Q80820466 | ||
| Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery | Q81747855 | ||
| Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controls | Q84981661 | ||
| Leptin: the link between overweight and primary hyperparathyroidism? | Q85000649 | ||
| Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis | Q29619487 | ||
| Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism | Q29620323 | ||
| True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery | Q33591322 | ||
| The association of adiposity with parathyroid hormone in healthy older adults | Q33904929 | ||
| Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study | Q34053046 | ||
| Evidence for alteration of the vitamin D-endocrine system in obese subjects | Q34544714 | ||
| Adipokines as novel biomarkers and regulators of the metabolic syndrome | Q34786187 | ||
| Vitamin D and hyperparathyroidism in obesity | Q35468562 | ||
| Severe Obesity Is Associated with Symptomatic Presentation, Higher Parathyroid Hormone Levels, and Increased Gland Weight in Primary Hyperparathyroidism | Q35494143 | ||
| Mechanobiology of the skeleton. | Q36141041 | ||
| Leptin and cancer. | Q36234841 | ||
| Bone density of the radius, spine, and hip in relation to percent of ideal body weight in postmenopausal women | Q36432055 | ||
| Osteocytes, mechanosensing and Wnt signaling | Q36595560 | ||
| The role of obesity and its bioclinical correlates in the progression of chronic kidney disease | Q36625291 | ||
| A multicenter study of the influence of fat and lean mass on bone mineral content: evidence for differences in their relative influence at major fracture sites. Early Postmenopausal Intervention Cohort (EPIC) Study Group. | Q36816379 | ||
| Mechanical signaling for bone modeling and remodeling | Q37094497 | ||
| Calcium metabolism in health and disease | Q37678706 | ||
| Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women | Q38296081 | ||
| Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization | Q38297886 | ||
| Leptin is a potent stimulator of bone growth in ob/ob mice | Q38307707 | ||
| Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice | Q38346068 | ||
| Serum leptin level is a predictor of bone mineral density in postmenopausal women. | Q40654244 | ||
| Leptin receptor isoform expression in rat osteoblasts and their functional analysis. | Q40701738 | ||
| Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density | Q40989858 | ||
| Secondary hyperparathyroidism of morbid obesity regresses during weight reduction | Q41436637 | ||
| Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women | Q43705369 | ||
| Leptin and bone mineral density: a cross-sectional study in obese and nonobese men. | Q43731282 | ||
| Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass | Q44786935 | ||
| Effect of fibroblast growth factor-23 on phosphate transport in proximal tubules | Q46654185 | ||
| Calcium metabolism in the morbidly obese | Q46700560 | ||
| Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. | Q47393739 | ||
| Plasma leptin concentration and change in bone density among elderly men and women: the Hertfordshire Cohort Study. | Q47426111 | ||
| Effects of vertical-banded gastroplasty on bone and mineral metabolism in obese patients. | Q50988104 | ||
| Serum leptin levels are associated with bone mass in nonobese women. | Q51549245 | ||
| Mineralized tissue cells are a principal source of FGF23. | Q51992228 | ||
| Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals | Q56109646 | ||
| Adiposity in Relation to Vitamin D Status and Parathyroid Hormone Levels: A Population-Based Study in Older Men and Women | Q57321529 | ||
| Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo | Q57533674 | ||
| Leptin, Body Composition and Bone Mineral Density in Premenopausal Women | Q58112098 | ||
| Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women | Q59587217 | ||
| Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study | Q59713575 | ||
| Determinants of total body and regional bone mineral density in normal postmenopausal women--a key role for fat mass | Q68185160 | ||
| Perspectives: some roles of mechanical usage, muscle strength, and the mechanostat in skeletal physiology, disease, and research | Q73956687 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 1655-1662 | |
| P577 | publication date | 2012-02-22 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity | |
| P478 | volume | 97 |
| Q34334299 | Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study |
| Q64116106 | Are serum leptin levels predicted by lipoproteins, vitamin D and body composition? |
| Q58726402 | Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus |
| Q37722933 | Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension: MESA (Multi-Ethnic Study of Atherosclerosis). |
| Q94525942 | Association of Serum Fibroblast Growth Factor 23 Levels with the Presence and Severity of Hepatic Steatosis Is Independent of Sleep Duration in Patients with Diabetes |
| Q39018695 | Bariatric Roux-En-Y Gastric Bypass Surgery: Adipocyte Proteins Involved in Increased Bone Remodeling in Humans |
| Q35755044 | Bone Remodeling and Energy Metabolism: New Perspectives. |
| Q35743594 | Bone loss after bariatric surgery: causes, consequences, and management |
| Q33999013 | Bone mineral content in patients with congenital generalized lipodystrophy is unaffected by metreleptin replacement therapy |
| Q64971507 | DObesity: Relationship between vitamin D deficiency, obesity and sclerostin as a novel biomarker of bone metabolism. |
| Q38625798 | Effects of short-term dry immersion on bone remodeling markers, insulin and adipokines. |
| Q38123396 | FGF-23 and secondary hyperparathyroidism in chronic kidney disease |
| Q88238584 | Fibroblast Growth Factor 23 is Associated With Adiposity in Patients Receiving Hemodialysis: Possible Cross Talk Between Bone and Adipose Tissue |
| Q34255342 | Fibroblast growth factor-23 in obese, normotensive adolescents is associated with adverse cardiac structure |
| Q45324535 | Genome-wide profiling of bone reveals differentially methylated regions in osteoporosis and osteoarthritis |
| Q83985552 | Glucose intolerance and primary hyperparathyroidism: an unresolved relationship |
| Q35794852 | Glycerol Production from Glucose and Fructose by 3T3-L1 Cells: A Mechanism of Adipocyte Defense from Excess Substrate |
| Q35967442 | Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men? |
| Q35556238 | High prevalence of metabolic syndrome in a mestizo group of adult patients with primary hyperparathyroidism (PHPT) |
| Q45340912 | Higher circulating parathormone is associated with smaller and weaker bones in obese children |
| Q39037907 | Hormonal and systemic regulation of sclerostin |
| Q41305100 | Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly. |
| Q34650666 | Iron and obesity status-associated insulin resistance influence circulating fibroblast-growth factor-23 concentrations |
| Q47172465 | Is There Any Relationship between Plasma 25-Hydroxyvitamin D₃, Adipokine Profiles and Excessive Body Weight in Type 2 Diabetic Patients? |
| Q54105684 | Leptin directly stimulates parathyroid hormone secretion. |
| Q48160398 | Leptin regulates disc cartilage endplate degeneration and ossification through activation of the MAPK-ERK signalling pathway in vivo and in vitro |
| Q36301066 | Long-term hypovitaminosis D and secondary hyperparathyroidism outcomes of the Roux-en-Y gastric bypass: a systematic review. |
| Q89478422 | Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis |
| Q53663111 | Markers of Bone Metabolism in Obese Individuals Undergoing Laparoscopic Sleeve Gastrectomy. |
| Q36587833 | Nontraditional manifestations of primary hyperparathyroidism. |
| Q33925973 | Osteocyte-Secreted Wnt Signaling Inhibitor Sclerostin Contributes to Beige Adipogenesis in Peripheral Fat Depots. |
| Q47175744 | Parathyroid hormone in surgery-induced weight loss: no glucometabolic effects but potential adaptive response to skeletal loading |
| Q53610476 | Parathyroid hormone reflects adiposity and cardiometabolic indices but not bone density in normal men. |
| Q44834439 | Persistent hyperparathyroidism is a major risk factor for fractures in the five years after kidney transplantation |
| Q36190921 | Physical activity may be a potent regulator of bone turnover biomarkers in healthy girls during preadolescence. |
| Q64108575 | Plasma Fibroblast Growth Factor 23 Is Elevated in Pediatric Primary Hypertension |
| Q38121133 | Potential health concerns of dietary phosphorus: cancer, obesity, and hypertension |
| Q52564608 | Predictive Factors of Secondary Normocalcemic Hyperparathyroidism after Roux-en-Y Gastric Bypass. |
| Q36820702 | Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women |
| Q47163438 | Serum leptin and skeletal differences between obese and non-obese patients with chronic obstructive pulmonary disease |
| Q37671206 | Standardized serum 25-hydroxyvitamin D concentrations are inversely associated with cardiometabolic disease in U.S. adults: a cross-sectional analysis of NHANES, 2001-2010. |
| Q47229371 | The Effect of a Muscle Weight-Bearing and Aerobic Exercise Program on the Body Composition, Muscular Strength, Biochemical Markers, and Bone Mass of Obese Patients Who Have Undergone Gastric Bypass Surgery. |
| Q91711350 | The Interplay Between Bone and Glucose Metabolism |
| Q30234616 | The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes |
| Q34676274 | The association of 25 hydroxyvitamin D and parathyroid hormone with metabolic syndrome in two ethnic groups in South Africa |
| Q33570171 | The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea |
| Q36609595 | The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes |
| Q51161134 | The relationship between postmenopausal women's sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products. |
| Q55405985 | Thin bones: Vitamin D and calcium handling after bariatric surgery. |
| Q46461611 | Visceral adiposity is a predictor of parathyroid hormone levels in healthy adults |
| Q39012131 | Vitamin D alteration associated with obesity and bariatric surgery |
| Q47581707 | Vitamin D levels in a paediatric population of normal weight and obese subjects |
| Q53774698 | Vitamin D status in children and adolescents with autoimmune thyroiditis. |
Search more.